Monoclonal Antibodies
Anti-SARS-CoV Spike RBD Monoclonal Antibody for WB, ELISA - P59594
Item Number : CM0006970
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- SARS-CoV
- Protein Weight
- 139kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | SARS-CoV Spike RBD Rabbit mAb |
| Remarks/Alias | E2; SARS-CoV Spike RBD |
| Gene ID | 1489668 |
| Immunogen | Synthetic peptide corresponding to a sequence within amino acids 350-450 of coronavirus SARS-CoV Spike RBD (NP_828851.1) |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | SARS-CoV |
| SWISS | P59594 |
| Protein Weight | 139kDa |
| Shipping | Ice bag |
Biological Background: SARS-CoV Spike RBD Function and Localization
- The Spike glycoprotein, also known as E2 or peplomer protein, is a 139 kDa class I viral fusion protein encoded by the S gene of SARS-CoV (UniProt P59594).
- It mediates viral attachment to host cells by binding to receptors such as human ACE2 and CLEC4M/DC-SIGNR, triggering internalization into endosomes (By similarity).
- Following endocytosis, cathepsin CTSL proteolysis unmasks the fusion peptide in the S2 subunit, activating membrane fusion between the viral envelope and host endosomal membrane.
- The protein also down-regulates host tetherin (BST2) via lysosomal degradation, counteracting innate antiviral activity.
- Subcellular localization includes the virion membrane, host endoplasmic reticulum-Golgi intermediate compartment membrane, and host cell membrane.
- Structural features include a signal peptide, coiled coil heptad repeats, disulfide bonds, a transmembrane helix, and palmitoylation, all essential for its fusogenic function.
- Keywords: Viral envelope protein, virus entry, host-virus interaction, immunoevasion, fusion of virus membrane with host membrane.
Experimental Guidance and Technical Tips
- The immunogen corresponds to residues 350–450 of the Spike RBD; the resulting antibody is expected to recognize the native RBD in Western blot under reducing or non-reducing conditions.
- For ELISA, consider this monoclonal antibody as a capture or detection reagent; matrix effects and dynamic range should be empirically determined.
- Validate specificity and cross-reactivity in the relevant experimental system (e.g., SARS-CoV infected cell lysates or recombinant RBD proteins).
- No cross-reactivity data are provided for other coronaviruses; testing is recommended if broad reactivity is required.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio streamlines IVD raw-material procurement for SARS-CoV spike research and diagnostic development. We offer validated monoclonal antibodies like this anti-RBD clone, alongside optimized antibody pairs, bulk ancillary reagents, and sourcing support for rare targets. Reach out to explore how CamelBio can accelerate your project from concept to clinic.
Product Datasheet
Anti-SARS-CoV Spike RBD Monoclonal Antibody for WB, ELISA - P59594
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!